Procurement Summary
Country : USA
Summary : Maximally Tolerated Dose (Mtd) and 14-Day Dose Range-Finding (Drf) Toxicity Study in Male and Female Rats for Ncats Etb.
Deadline : 03 Aug 2023
Other Information
Notice Type : Tender
TOT Ref.No.: 86564157
Document Ref. No. : 75N95023Q00536
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
COMBINED SYNOPSIS / SOLICITATION
75N95023Q00536
TITLE: Maximally tolerated dose (MTD) and 14-Day Dose Range-Finding (DRF) Toxicity Study in Male and female rats for NCATS ETB.
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested and a written solicitation will not be issued.
(ii) The solicitation number is 75N95023Q00536 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13 - Simplified Acquisition Procedures and FAR Part 12 - Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2023-04, effective June 2, 2023.
(iv) The associated NAICS code is 541380 and the Small Business size standard is $19M. This requirement is non-competitive and no set-aside restrictions are applicable.
THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to Pharmaron, Inc., 201 E Jefferson St., Louisville, KY 40202-1246. To ensure consistency among data, the current study must be conducted by the same vendor that conducted prior studies. Therefore, to ensure the continuity of scie...
Active Contract Opportunity
Notice ID : 75N95023Q00536
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office : NATIONAL INSTITUTES OF HEALTH NIDA
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Jul 31, 2023 09:38 am EDT
Original Date Offers Due: Aug 03, 2023 03:00 pm EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Aug 18, 2023
Initiative: None
Classification
Original Set Aside:
Product Service Code: Q301 - MEDICAL- LABORATORY TESTING
NAICS Code: 541380 - Testing Laboratories and Services
Place of Performance: USA
Documents
Tender Notice